

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine deamination (GO:0009972) | 8.86816365 |
| 2 | cytidine metabolic process (GO:0046087) | 8.86816365 |
| 3 | cytidine catabolic process (GO:0006216) | 8.86816365 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 8.67107446 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.92768568 |
| 6 | cellular response to zinc ion (GO:0071294) | 7.55109450 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.85606195 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.63975602 |
| 9 | regulation of B cell differentiation (GO:0045577) | 6.19339351 |
| 10 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 6.16002202 |
| 11 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 6.16002202 |
| 12 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.44329663 |
| 13 | positive thymic T cell selection (GO:0045059) | 5.30080958 |
| 14 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.16774398 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 5.15331825 |
| 16 | regulation of B cell proliferation (GO:0030888) | 4.94955598 |
| 17 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.92222806 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.82506499 |
| 19 | negative regulation of B cell proliferation (GO:0030889) | 4.82134122 |
| 20 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.81322157 |
| 21 | mature B cell differentiation (GO:0002335) | 4.76130970 |
| 22 | * B cell proliferation (GO:0042100) | 4.70648124 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.62773532 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.62773532 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 4.62773532 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 4.62773532 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 4.62773532 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.62773532 |
| 29 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.61683419 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.57820466 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.57820466 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 4.56821954 |
| 33 | regulation of germinal center formation (GO:0002634) | 4.55082468 |
| 34 | regulation of B cell apoptotic process (GO:0002902) | 4.54458409 |
| 35 | negative regulation of cell killing (GO:0031342) | 4.48022591 |
| 36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.48022591 |
| 37 | B cell homeostasis (GO:0001782) | 4.46532854 |
| 38 | regulation of antigen processing and presentation (GO:0002577) | 4.35993934 |
| 39 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.29481092 |
| 40 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.24335967 |
| 41 | positive regulation of B cell proliferation (GO:0030890) | 4.23910919 |
| 42 | germinal center formation (GO:0002467) | 4.22827336 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 4.19722139 |
| 44 | negative thymic T cell selection (GO:0045060) | 4.19032955 |
| 45 | detection of bacterium (GO:0016045) | 4.17875644 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.15735693 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.10811442 |
| 48 | negative regulation of B cell apoptotic process (GO:0002903) | 4.07343844 |
| 49 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.03982589 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 4.03421828 |
| 51 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.00717576 |
| 52 | type I interferon signaling pathway (GO:0060337) | 3.96902589 |
| 53 | cellular response to type I interferon (GO:0071357) | 3.96902589 |
| 54 | response to type I interferon (GO:0034340) | 3.95550331 |
| 55 | * B cell activation (GO:0042113) | 3.93819006 |
| 56 | detection of other organism (GO:0098543) | 3.92282781 |
| 57 | response to interleukin-15 (GO:0070672) | 3.84434611 |
| 58 | negative T cell selection (GO:0043383) | 3.84017586 |
| 59 | complement activation, classical pathway (GO:0006958) | 3.80453489 |
| 60 | T cell migration (GO:0072678) | 3.78775247 |
| 61 | somatic diversification of immunoglobulins (GO:0016445) | 3.78223487 |
| 62 | positive T cell selection (GO:0043368) | 3.75035133 |
| 63 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.73672449 |
| 64 | negative regulation of gene silencing (GO:0060969) | 3.72675234 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 3.71019908 |
| 66 | lymphocyte homeostasis (GO:0002260) | 3.70748862 |
| 67 | thymic T cell selection (GO:0045061) | 3.70664357 |
| 68 | regulation of B cell activation (GO:0050864) | 3.68175683 |
| 69 | B cell activation involved in immune response (GO:0002312) | 3.67219654 |
| 70 | mature B cell differentiation involved in immune response (GO:0002313) | 3.66774598 |
| 71 | defense response to protozoan (GO:0042832) | 3.62650529 |
| 72 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.58791387 |
| 73 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.58791387 |
| 74 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.58791387 |
| 75 | positive regulation of B cell activation (GO:0050871) | 3.58485486 |
| 76 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.53266042 |
| 77 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.53237047 |
| 78 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.47061579 |
| 79 | T cell selection (GO:0045058) | 3.45409969 |
| 80 | regulation of histone H3-K27 methylation (GO:0061085) | 3.41197757 |
| 81 | lymph node development (GO:0048535) | 3.40765055 |
| 82 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.40055497 |
| 83 | positive regulation of antigen processing and presentation (GO:0002579) | 3.37944523 |
| 84 | negative regulation of phagocytosis (GO:0050765) | 3.36169117 |
| 85 | positive regulation of Rap GTPase activity (GO:0032854) | 3.35342847 |
| 86 | negative regulation of histone methylation (GO:0031061) | 3.32083078 |
| 87 | NIK/NF-kappaB signaling (GO:0038061) | 3.31612184 |
| 88 | histamine secretion (GO:0001821) | 3.31435686 |
| 89 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.30991730 |
| 90 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.29482071 |
| 91 | respiratory burst (GO:0045730) | 3.28781693 |
| 92 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.27542209 |
| 93 | natural killer cell mediated immunity (GO:0002228) | 3.27542209 |
| 94 | negative regulation of B cell mediated immunity (GO:0002713) | 3.27229321 |
| 95 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.27229321 |
| 96 | B cell differentiation (GO:0030183) | 3.26291164 |
| 97 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.25338380 |
| 98 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.25050242 |
| 99 | response to host immune response (GO:0052572) | 3.25050242 |
| 100 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 3.24733567 |
| 101 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.24271074 |
| 102 | negative regulation of humoral immune response (GO:0002921) | 3.23632809 |
| 103 | positive regulation of humoral immune response (GO:0002922) | 3.23312762 |
| 104 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.23141510 |
| 105 | detection of external biotic stimulus (GO:0098581) | 3.20886451 |
| 106 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.20715229 |
| 107 | isotype switching (GO:0045190) | 3.20715229 |
| 108 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.20715229 |
| 109 | positive regulation of interferon-alpha production (GO:0032727) | 3.19421096 |
| 110 | T cell costimulation (GO:0031295) | 3.17766494 |
| 111 | leukocyte homeostasis (GO:0001776) | 3.17151248 |
| 112 | regulation of chromatin silencing (GO:0031935) | 3.14287107 |
| 113 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.11761794 |
| 114 | cellular response to interferon-gamma (GO:0071346) | 3.11480374 |
| 115 | lymphocyte costimulation (GO:0031294) | 3.10199975 |
| 116 | positive regulation of immunoglobulin production (GO:0002639) | 3.10109786 |
| 117 | * lymphocyte proliferation (GO:0046651) | 3.08729875 |
| 118 | T cell lineage commitment (GO:0002360) | 3.08354768 |
| 119 | * mononuclear cell proliferation (GO:0032943) | 3.06853113 |
| 120 | cellular response to exogenous dsRNA (GO:0071360) | 3.06522378 |
| 121 | positive regulation of type 2 immune response (GO:0002830) | 3.04312125 |
| 122 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.03962943 |
| 123 | regulation of interferon-alpha production (GO:0032647) | 3.02420563 |
| 124 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.02268867 |
| 125 | B cell mediated immunity (GO:0019724) | 3.01829325 |
| 126 | response to host (GO:0075136) | 3.01742567 |
| 127 | response to host defenses (GO:0052200) | 3.01742567 |
| 128 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.01742567 |
| 129 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.01396074 |
| 130 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.01330073 |
| 131 | positive regulation of macrophage cytokine production (GO:0060907) | 3.00770619 |
| 132 | T-helper 1 type immune response (GO:0042088) | 2.99519627 |
| 133 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.98356289 |
| 134 | positive regulation of interferon-beta production (GO:0032728) | 2.97984753 |
| 135 | positive regulation of interleukin-2 production (GO:0032743) | 2.97646160 |
| 136 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.93992829 |
| 137 | response to protozoan (GO:0001562) | 2.93844011 |
| 138 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93426964 |
| 139 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92783178 |
| 140 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.85686094 |
| 141 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.85362908 |
| 142 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.84756629 |
| 143 | regulation of interferon-beta production (GO:0032648) | 2.83797336 |
| 144 | adaptive immune response (GO:0002250) | 2.79904924 |
| 145 | B cell receptor signaling pathway (GO:0050853) | 10.3467630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.64675633 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.40878376 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.25996649 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.05164120 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 4.80587706 |
| 6 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.75105094 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.45993212 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.32098626 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.15956129 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.12864444 |
| 11 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.08551057 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.95547517 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.64794229 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.56143170 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.47932531 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.45326629 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.42840169 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.42049398 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.37663365 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.37610779 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.23449208 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.16569806 |
| 23 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.13426567 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 2.11600132 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11364852 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.06217148 |
| 27 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05901095 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00704143 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.99468669 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99237485 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93302965 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93235022 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80603201 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.79418477 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79279756 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.75594686 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74234092 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69447188 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69009935 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65450656 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61127056 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59394906 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56138981 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.55469143 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55296405 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49573529 |
| 47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48855977 |
| 48 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.47765526 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47636556 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.46907483 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39156627 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38510632 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34887829 |
| 54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33695591 |
| 55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32067657 |
| 56 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.30830207 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30711077 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29638540 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26568159 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.26400901 |
| 61 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26329343 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23260916 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21444049 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15687843 |
| 65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13766293 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07561628 |
| 67 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.04786517 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03372666 |
| 69 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.02588599 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02310158 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01688255 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99452610 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97876203 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96322075 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95673267 |
| 76 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.94065848 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93940983 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93529776 |
| 79 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92816056 |
| 80 | GATA3_26560356_Chip-Seq_TH1_Human | 0.92580185 |
| 81 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91780231 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90506135 |
| 83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90441651 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88838816 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88651059 |
| 86 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88112249 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85531098 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84925090 |
| 89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84905499 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 0.84523917 |
| 91 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84262894 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84030034 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83380540 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82485942 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80952916 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79127971 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.77599863 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75095930 |
| 99 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.74077237 |
| 100 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73777905 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73104806 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72923443 |
| 103 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72913895 |
| 104 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72530118 |
| 105 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.72258127 |
| 106 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.71336855 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70984151 |
| 108 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70872341 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70199008 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69814274 |
| 111 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.68561208 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68316740 |
| 113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.68286713 |
| 114 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.67063418 |
| 115 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.65918658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.34661767 |
| 2 | MP0001800_abnormal_humoral_immune | 5.51064418 |
| 3 | MP0005387_immune_system_phenotype | 5.33169432 |
| 4 | MP0001790_abnormal_immune_system | 5.33169432 |
| 5 | MP0000685_abnormal_immune_system | 4.14679319 |
| 6 | * MP0002452_abnormal_antigen_presenting | 4.03612234 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.52335021 |
| 8 | MP0005671_abnormal_response_to | 3.41579465 |
| 9 | MP0003303_peritoneal_inflammation | 3.40935013 |
| 10 | MP0002723_abnormal_immune_serum | 3.33794585 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 3.22597094 |
| 12 | * MP0001819_abnormal_immune_cell | 3.09777615 |
| 13 | * MP0002398_abnormal_bone_marrow | 2.98558488 |
| 14 | MP0000689_abnormal_spleen_morphology | 2.77264822 |
| 15 | * MP0000716_abnormal_immune_system | 2.71954866 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.40668861 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.23185441 |
| 18 | * MP0002429_abnormal_blood_cell | 2.21442764 |
| 19 | MP0002722_abnormal_immune_system | 2.17402827 |
| 20 | MP0005025_abnormal_response_to | 2.05487010 |
| 21 | MP0004510_myositis | 1.96653644 |
| 22 | MP0002419_abnormal_innate_immunity | 1.96043108 |
| 23 | MP0001348_abnormal_lacrimal_gland | 1.91411015 |
| 24 | MP0002166_altered_tumor_susceptibility | 1.89172369 |
| 25 | MP0008057_abnormal_DNA_replication | 1.86452112 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.78811231 |
| 27 | MP0001873_stomach_inflammation | 1.76718661 |
| 28 | MP0009785_altered_susceptibility_to | 1.76709520 |
| 29 | MP0001853_heart_inflammation | 1.75042462 |
| 30 | MP0002405_respiratory_system_inflammati | 1.72567189 |
| 31 | MP0005310_abnormal_salivary_gland | 1.65920773 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.65695147 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.63901698 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.58739674 |
| 35 | MP0003724_increased_susceptibility_to | 1.57456084 |
| 36 | MP0010094_abnormal_chromosome_stability | 1.56032304 |
| 37 | MP0002933_joint_inflammation | 1.53829398 |
| 38 | MP0000703_abnormal_thymus_morphology | 1.40219459 |
| 39 | MP0003436_decreased_susceptibility_to | 1.35460322 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.34967780 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.31898122 |
| 42 | MP0004947_skin_inflammation | 1.31851088 |
| 43 | MP0002006_tumorigenesis | 1.31216015 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.28679843 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.26202586 |
| 46 | MP0003077_abnormal_cell_cycle | 1.22313780 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.19004506 |
| 48 | MP0003787_abnormal_imprinting | 1.18080614 |
| 49 | MP0003866_abnormal_defecation | 1.12572605 |
| 50 | MP0002019_abnormal_tumor_incidence | 1.10878099 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.10667304 |
| 52 | MP0002136_abnormal_kidney_physiology | 1.08557969 |
| 53 | MP0001879_abnormal_lymphatic_vessel | 1.03815535 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.01156384 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 0.99846002 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 0.99129563 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 0.97542056 |
| 58 | MP0002163_abnormal_gland_morphology | 0.96908489 |
| 59 | MP0004381_abnormal_hair_follicle | 0.95994838 |
| 60 | MP0005174_abnormal_tail_pigmentation | 0.95817278 |
| 61 | MP0000371_diluted_coat_color | 0.86652009 |
| 62 | MP0002909_abnormal_adrenal_gland | 0.86296496 |
| 63 | MP0008469_abnormal_protein_level | 0.85547013 |
| 64 | MP0003091_abnormal_cell_migration | 0.83919487 |
| 65 | MP0002095_abnormal_skin_pigmentation | 0.82976654 |
| 66 | MP0000015_abnormal_ear_pigmentation | 0.81332765 |
| 67 | MP0003111_abnormal_nucleus_morphology | 0.81299623 |
| 68 | MP0006054_spinal_hemorrhage | 0.80741037 |
| 69 | MP0000858_altered_metastatic_potential | 0.79024267 |
| 70 | MP0003693_abnormal_embryo_hatching | 0.78551943 |
| 71 | MP0000013_abnormal_adipose_tissue | 0.77401528 |
| 72 | MP0005379_endocrine/exocrine_gland_phen | 0.73936897 |
| 73 | MP0002928_abnormal_bile_duct | 0.73733285 |
| 74 | MP0008260_abnormal_autophagy | 0.71293683 |
| 75 | MP0001533_abnormal_skeleton_physiology | 0.69951013 |
| 76 | MP0003045_fibrosis | 0.69629660 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.68430441 |
| 78 | MP0008874_decreased_physiological_sensi | 0.63195588 |
| 79 | MP0000350_abnormal_cell_proliferation | 0.63057246 |
| 80 | MP0003252_abnormal_bile_duct | 0.63024607 |
| 81 | MP0008877_abnormal_DNA_methylation | 0.61742385 |
| 82 | MP0009764_decreased_sensitivity_to | 0.61220172 |
| 83 | MP0008058_abnormal_DNA_repair | 0.59671518 |
| 84 | MP0002132_abnormal_respiratory_system | 0.59501664 |
| 85 | MP0005621_abnormal_cell_physiology | 0.56912678 |
| 86 | MP0004957_abnormal_blastocyst_morpholog | 0.56314948 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.54831028 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.54343237 |
| 89 | MP0001191_abnormal_skin_condition | 0.54162016 |
| 90 | MP0004883_abnormal_blood_vessel | 0.53505376 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52704449 |
| 92 | MP0000313_abnormal_cell_death | 0.52425007 |
| 93 | MP0002139_abnormal_hepatobiliary_system | 0.51890196 |
| 94 | MP0005166_decreased_susceptibility_to | 0.50432973 |
| 95 | MP0002083_premature_death | 0.50360822 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 0.50089457 |
| 97 | MP0001545_abnormal_hematopoietic_system | 0.50089457 |
| 98 | MP0000249_abnormal_blood_vessel | 0.49951016 |
| 99 | MP0009278_abnormal_bone_marrow | 0.49053929 |
| 100 | MP0000490_abnormal_crypts_of | 0.48948844 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.48169313 |
| 102 | MP0002693_abnormal_pancreas_physiology | 0.46424206 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.45960664 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.45610147 |
| 105 | MP0005451_abnormal_body_composition | 0.45568521 |
| 106 | MP0001663_abnormal_digestive_system | 0.45392314 |
| 107 | MP0006082_CNS_inflammation | 0.45095334 |
| 108 | MP0003786_premature_aging | 0.44576777 |
| 109 | MP0000609_abnormal_liver_physiology | 0.44376544 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43536459 |
| 111 | MP0002168_other_aberrant_phenotype | 0.42742773 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.42602824 |
| 113 | MP0009115_abnormal_fat_cell | 0.41764488 |
| 114 | MP0003828_pulmonary_edema | 0.41333702 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.40667316 |
| 116 | MP0002009_preneoplasia | 0.39907822 |
| 117 | MP0002135_abnormal_kidney_morphology | 0.39124440 |
| 118 | MP0001958_emphysema | 0.38517163 |
| 119 | MP0005384_cellular_phenotype | 0.36842458 |
| 120 | MP0001730_embryonic_growth_arrest | 0.36291241 |
| 121 | MP0009763_increased_sensitivity_to | 0.33074310 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.30816951 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.30666824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Gastrointestinal stroma tumor (HP:0100723) | 8.29374671 |
| 2 | Recurrent sinusitis (HP:0011108) | 7.68725414 |
| 3 | Recurrent bronchitis (HP:0002837) | 7.39477009 |
| 4 | Cellulitis (HP:0100658) | 6.49645658 |
| 5 | Colitis (HP:0002583) | 6.45414554 |
| 6 | IgA deficiency (HP:0002720) | 5.62223145 |
| 7 | Verrucae (HP:0200043) | 5.60858998 |
| 8 | Papilloma (HP:0012740) | 5.60858998 |
| 9 | IgM deficiency (HP:0002850) | 5.49125820 |
| 10 | Chronic sinusitis (HP:0011109) | 5.29976930 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.22540956 |
| 12 | Inflammation of the large intestine (HP:0002037) | 5.22115046 |
| 13 | Recurrent lower respiratory tract infections (HP:0002783) | 5.12119099 |
| 14 | * Lymphopenia (HP:0001888) | 5.11167715 |
| 15 | Gastrointestinal inflammation (HP:0004386) | 4.98686398 |
| 16 | Recurrent pneumonia (HP:0006532) | 4.97093927 |
| 17 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.94744983 |
| 18 | Recurrent viral infections (HP:0004429) | 4.82026911 |
| 19 | Meningitis (HP:0001287) | 4.78553282 |
| 20 | * Emphysema (HP:0002097) | 4.73476340 |
| 21 | Panhypogammaglobulinemia (HP:0003139) | 4.56366142 |
| 22 | Bronchitis (HP:0012387) | 4.27163723 |
| 23 | Recurrent otitis media (HP:0000403) | 4.23477996 |
| 24 | Osteomyelitis (HP:0002754) | 4.07448574 |
| 25 | * Vasculitis (HP:0002633) | 4.06004469 |
| 26 | IgG deficiency (HP:0004315) | 4.01294326 |
| 27 | Small epiphyses (HP:0010585) | 3.83428201 |
| 28 | Chronic otitis media (HP:0000389) | 3.66653119 |
| 29 | * Restrictive lung disease (HP:0002091) | 3.62727079 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.58991947 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.58991947 |
| 32 | Recurrent abscess formation (HP:0002722) | 3.52722716 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 3.41285769 |
| 34 | Sepsis (HP:0100806) | 3.32273329 |
| 35 | B lymphocytopenia (HP:0010976) | 3.28861726 |
| 36 | Abnormality of B cell number (HP:0010975) | 3.28861726 |
| 37 | Recurrent fungal infections (HP:0002841) | 3.26073223 |
| 38 | Viral hepatitis (HP:0006562) | 3.20803477 |
| 39 | Chronic diarrhea (HP:0002028) | 3.18101900 |
| 40 | Thyroiditis (HP:0100646) | 3.17631408 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 3.14470248 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 3.12642706 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 3.07493002 |
| 44 | Mitral stenosis (HP:0001718) | 2.96229636 |
| 45 | Recurrent skin infections (HP:0001581) | 2.95059526 |
| 46 | * Leukopenia (HP:0001882) | 2.85725357 |
| 47 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.78001793 |
| 48 | Abnormality of T cells (HP:0002843) | 2.77863867 |
| 49 | Abnormality of macrophages (HP:0004311) | 2.73336695 |
| 50 | * Lymphoma (HP:0002665) | 2.71532865 |
| 51 | Vertebral arch anomaly (HP:0008438) | 2.71459096 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.69046709 |
| 53 | Optic neuritis (HP:0100653) | 2.58326349 |
| 54 | Retrobulbar optic neuritis (HP:0100654) | 2.58326349 |
| 55 | Calf muscle hypertrophy (HP:0008981) | 2.53401542 |
| 56 | Skin rash (HP:0000988) | 2.52963901 |
| 57 | Abnormality of the fingertips (HP:0001211) | 2.52782899 |
| 58 | Encephalitis (HP:0002383) | 2.50040920 |
| 59 | Urticaria (HP:0001025) | 2.50026758 |
| 60 | Eczematoid dermatitis (HP:0000976) | 2.44155905 |
| 61 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.42889643 |
| 62 | Increased IgM level (HP:0003496) | 2.38842338 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.38485120 |
| 64 | Papilledema (HP:0001085) | 2.35348884 |
| 65 | Flattened epiphyses (HP:0003071) | 2.32027419 |
| 66 | Hypoplasia of the thymus (HP:0000778) | 2.31839368 |
| 67 | Neutropenia (HP:0001875) | 2.31479776 |
| 68 | Abnormality of T cell number (HP:0011839) | 2.30545252 |
| 69 | Chest pain (HP:0100749) | 2.29465457 |
| 70 | Orchitis (HP:0100796) | 2.24034644 |
| 71 | Myositis (HP:0100614) | 2.22440026 |
| 72 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.20504619 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.20386172 |
| 74 | Skin ulcer (HP:0200042) | 2.19471072 |
| 75 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.18822566 |
| 76 | Absent epiphyses (HP:0010577) | 2.18822566 |
| 77 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.18064524 |
| 78 | Villous atrophy (HP:0011473) | 2.18064524 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 2.13520898 |
| 80 | Interstitial pulmonary disease (HP:0006530) | 2.11088837 |
| 81 | Irregular vertebral endplates (HP:0003301) | 2.10607674 |
| 82 | Xerostomia (HP:0000217) | 2.10394973 |
| 83 | T lymphocytopenia (HP:0005403) | 2.10274839 |
| 84 | Thrombocytosis (HP:0001894) | 2.10120607 |
| 85 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07073318 |
| 86 | Obstructive lung disease (HP:0006536) | 2.07073318 |
| 87 | Keratoconjunctivitis sicca (HP:0001097) | 2.03626060 |
| 88 | Pulmonary infiltrates (HP:0002113) | 2.03264310 |
| 89 | Hemoptysis (HP:0002105) | 2.00606911 |
| 90 | Agammaglobulinemia (HP:0004432) | 10.7403693 |
| 91 | Poikiloderma (HP:0001029) | 1.95814893 |
| 92 | Increased IgE level (HP:0003212) | 1.94976534 |
| 93 | Ulnar bowing (HP:0003031) | 1.93392480 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 1.93331729 |
| 95 | * Arthralgia (HP:0002829) | 1.92880620 |
| 96 | Hepatitis (HP:0012115) | 1.92752490 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 1.92122654 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 1.91763593 |
| 99 | Keratoconjunctivitis (HP:0001096) | 1.86084886 |
| 100 | Pustule (HP:0200039) | 1.85334502 |
| 101 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85152250 |
| 102 | Arthropathy (HP:0003040) | 1.83299593 |
| 103 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.83005527 |
| 104 | Hypertensive crisis (HP:0100735) | 1.82543716 |
| 105 | Hematochezia (HP:0002573) | 1.82073072 |
| 106 | Abnormality of male internal genitalia (HP:0000022) | 1.80210723 |
| 107 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.73418780 |
| 108 | Abnormality of eosinophils (HP:0001879) | 1.71015887 |
| 109 | Teleangiectasia of the skin (HP:0100585) | 1.68024182 |
| 110 | Fatigue (HP:0012378) | 1.67155222 |
| 111 | Spontaneous hematomas (HP:0007420) | 1.66314861 |
| 112 | Nasal polyposis (HP:0100582) | 1.64862059 |
| 113 | Basal cell carcinoma (HP:0002671) | 1.62956847 |
| 114 | Dehydration (HP:0001944) | 1.58135458 |
| 115 | Abnormality of the vertebral endplates (HP:0005106) | 1.57594411 |
| 116 | Eosinophilia (HP:0001880) | 1.56794350 |
| 117 | Hypochromic anemia (HP:0001931) | 1.55673737 |
| 118 | Acrocyanosis (HP:0001063) | 1.54326046 |
| 119 | Barrel-shaped chest (HP:0001552) | 1.54293427 |
| 120 | Combined immunodeficiency (HP:0005387) | 1.51478697 |
| 121 | Limb hypertonia (HP:0002509) | 1.51042021 |
| 122 | Mucosal telangiectasiae (HP:0100579) | 1.50958494 |
| 123 | Aortic regurgitation (HP:0001659) | 1.49796125 |
| 124 | Periodontitis (HP:0000704) | 1.47733165 |
| 125 | Bronchiectasis (HP:0002110) | 1.46157845 |
| 126 | Gingivitis (HP:0000230) | 1.44418113 |
| 127 | Granulocytopenia (HP:0001913) | 1.43551665 |
| 128 | Abnormality of the intervertebral disk (HP:0005108) | 1.40519879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 7.35948713 |
| 2 | BLK | 3.70984458 |
| 3 | CDK19 | 3.68687624 |
| 4 | SYK | 3.27293317 |
| 5 | CSF1R | 3.27008162 |
| 6 | GRK6 | 3.21356513 |
| 7 | ERN1 | 2.98491080 |
| 8 | BTK | 2.90001061 |
| 9 | RIPK4 | 2.75462634 |
| 10 | MAP3K13 | 2.54839542 |
| 11 | PRPF4B | 2.47921090 |
| 12 | LRRK2 | 2.38572144 |
| 13 | STK10 | 2.27423331 |
| 14 | MAP3K10 | 2.22218738 |
| 15 | MAP3K14 | 2.19686897 |
| 16 | LYN | 2.16639850 |
| 17 | GRK1 | 1.94307185 |
| 18 | KIT | 1.91740423 |
| 19 | MST4 | 1.80658012 |
| 20 | PRKCH | 1.71194008 |
| 21 | TYK2 | 1.71148312 |
| 22 | PRKCQ | 1.66501373 |
| 23 | JAK1 | 1.64135776 |
| 24 | SIK2 | 1.57682060 |
| 25 | IRAK3 | 1.55801742 |
| 26 | CSK | 1.54181681 |
| 27 | HCK | 1.44457554 |
| 28 | TEC | 1.35515216 |
| 29 | EIF2AK3 | 1.27039931 |
| 30 | CLK1 | 1.25879856 |
| 31 | ITK | 1.24749703 |
| 32 | PASK | 1.21445081 |
| 33 | IKBKB | 1.19089818 |
| 34 | SMG1 | 1.18858964 |
| 35 | MARK3 | 1.18555070 |
| 36 | TBK1 | 1.17488626 |
| 37 | IRAK4 | 1.16979995 |
| 38 | SIK3 | 1.15733587 |
| 39 | LCK | 1.15405089 |
| 40 | CDK12 | 1.15398677 |
| 41 | PRKCI | 1.13951345 |
| 42 | MAPK11 | 1.12447166 |
| 43 | MATK | 1.11313153 |
| 44 | CDC42BPA | 1.08845185 |
| 45 | ARAF | 1.08175642 |
| 46 | JAK3 | 1.03230423 |
| 47 | FRK | 1.00092806 |
| 48 | FES | 0.97657882 |
| 49 | ZAP70 | 0.86864472 |
| 50 | CCNB1 | 0.86720499 |
| 51 | TAOK3 | 0.84925928 |
| 52 | BRD4 | 0.84782534 |
| 53 | NEK2 | 0.77928281 |
| 54 | FGFR3 | 0.77153716 |
| 55 | TNK2 | 0.73826010 |
| 56 | TGFBR2 | 0.71694138 |
| 57 | MAPK7 | 0.68445904 |
| 58 | CSNK1A1L | 0.68328141 |
| 59 | KSR2 | 0.67351462 |
| 60 | IKBKE | 0.66450664 |
| 61 | ALK | 0.65338821 |
| 62 | PIM1 | 0.64456871 |
| 63 | PIK3CG | 0.63848357 |
| 64 | RPS6KA4 | 0.63780572 |
| 65 | ABL1 | 0.62055601 |
| 66 | FYN | 0.61546119 |
| 67 | TLK1 | 0.60775260 |
| 68 | INSR | 0.58894263 |
| 69 | EIF2AK1 | 0.58272863 |
| 70 | TESK2 | 0.58042299 |
| 71 | CHUK | 0.58004307 |
| 72 | JAK2 | 0.55735454 |
| 73 | MELK | 0.55471938 |
| 74 | MAP2K3 | 0.53033071 |
| 75 | PRKCD | 0.52449556 |
| 76 | MARK2 | 0.51983819 |
| 77 | MAP3K9 | 0.50224058 |
| 78 | CSNK1G3 | 0.50144993 |
| 79 | MAPK12 | 0.49469780 |
| 80 | SIK1 | 0.49352219 |
| 81 | STK4 | 0.48635395 |
| 82 | CDK4 | 0.48029649 |
| 83 | DYRK1B | 0.47536026 |
| 84 | CSNK1G1 | 0.47392338 |
| 85 | CDC7 | 0.47001241 |
| 86 | HIPK2 | 0.46572360 |
| 87 | FGR | 0.46515759 |
| 88 | PDPK1 | 0.46374749 |
| 89 | MAP3K1 | 0.44852370 |
| 90 | PDK1 | 0.44824147 |
| 91 | BMPR2 | 0.44493916 |
| 92 | TRIB3 | 0.44081201 |
| 93 | IRAK2 | 0.40288049 |
| 94 | FGFR4 | 0.39779242 |
| 95 | RAF1 | 0.39217435 |
| 96 | MAP2K1 | 0.37870611 |
| 97 | STK24 | 0.37723915 |
| 98 | TXK | 0.37683506 |
| 99 | CDK9 | 0.37532969 |
| 100 | RPS6KB1 | 0.36630604 |
| 101 | PRKD1 | 0.36236960 |
| 102 | PRKD2 | 0.35574948 |
| 103 | ATR | 0.34973737 |
| 104 | BRAF | 0.34310537 |
| 105 | IRAK1 | 0.33786476 |
| 106 | EEF2K | 0.32850265 |
| 107 | MAP3K8 | 0.32754871 |
| 108 | MAPK4 | 0.32501028 |
| 109 | DYRK3 | 0.31900756 |
| 110 | SCYL2 | 0.31802658 |
| 111 | MAPKAPK2 | 0.31624520 |
| 112 | CSNK1D | 0.30899914 |
| 113 | MAP3K7 | 0.30455610 |
| 114 | CSNK1G2 | 0.29312133 |
| 115 | EGFR | 0.28190888 |
| 116 | SGK3 | 0.27959967 |
| 117 | CHEK1 | 0.26594218 |
| 118 | NLK | 0.24831809 |
| 119 | NEK9 | 0.23940567 |
| 120 | ACVR1B | 0.23454371 |
| 121 | PRKCZ | 0.23225068 |
| 122 | MAP2K2 | 0.21066777 |
| 123 | PKN1 | 0.20635321 |
| 124 | FGFR2 | 0.20560133 |
| 125 | DYRK1A | 0.20299902 |
| 126 | BUB1 | 0.18454612 |
| 127 | CAMK1G | 0.17064834 |
| 128 | WNK1 | 0.16649904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.43686260 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 6.69975200 |
| 3 | Asthma_Homo sapiens_hsa05310 | 4.25912577 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.53022726 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.03366740 |
| 6 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.57361972 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.52269914 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.49366470 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.45716645 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.32080769 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.18921018 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 1.97127278 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89175372 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74123390 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.68442731 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64706512 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.59826476 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.52195913 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43717744 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.36495109 |
| 21 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.35253691 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30979998 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.28536643 |
| 24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23593231 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.22695119 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22457393 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17890568 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14724352 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.12024869 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05342108 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98565797 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97841108 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.96454022 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 0.95771199 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95200600 |
| 36 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94798577 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 0.93549856 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93216631 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.92398134 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 0.91259056 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 0.89763365 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.85325747 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84946314 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83491674 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82752096 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81312205 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80541220 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79707620 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.79447727 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 0.77960308 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76360547 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74434140 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73706726 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73423107 |
| 55 | Spliceosome_Homo sapiens_hsa03040 | 0.70623298 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68124296 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 0.66784367 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63015606 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61644388 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.57624196 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57034713 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56791596 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56676508 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52268681 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51977945 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51415877 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50881443 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49847352 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.48134997 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47468994 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.47399742 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46997215 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45744025 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.45619988 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41868661 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41712564 |
| 77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41263220 |
| 78 | Cell cycle_Homo sapiens_hsa04110 | 0.41094412 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40584337 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.37346084 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.34881469 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34015589 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32817128 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.32344106 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31700230 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31650229 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.31649171 |
| 88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.31280749 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30646252 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.30467132 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29403947 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29158140 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29115127 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28356957 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26560635 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.26521367 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25243584 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.24417981 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24160892 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.23350700 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21454562 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21097081 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20730146 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20546977 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.19590455 |
| 106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.18009789 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17905815 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.16541456 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15295211 |
| 110 | RNA transport_Homo sapiens_hsa03013 | 0.14077374 |
| 111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.14020514 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.13203928 |
| 113 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.12495728 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12478876 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.11466351 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.11252364 |
| 117 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.09157498 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.07925507 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.06351080 |

